✦ LIBER ✦

O114 RESULTS OF THE PHASE 2 STUDY M12-999: INTERFERON-FREE REGIMEN OF ABT-450/R/ABT-267 + ABT-333 + RIBAVIRIN IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV GENOTYPE 1 INFECTION

✍ Scribed by Kwo, P.; Mantry, P.; Coakley, E.; Te, H.; Vargas, H.; Brown, R.; Gordon, F.; Levitsky, J.; Terrault, N.; Burton, J.; Xie, W.; Setze, C.; Badri, P.; Vilchez, R.A.; Forns, X.

Book ID: 122983761
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 63 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60116-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3 SAFETY AND EFFICACY OF INTERFERON-FREE

3 SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333 +/− RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDY

✍ Kowdley, K.V.; Lawitz, E.; Poordad, F.; Cohen, D.E.; Nelson, D.; Zeuzem, S.; Eve 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 376 KB

O58 RESULTS FROM THE PHASE 2 PEARL-I STU

O58 RESULTS FROM THE PHASE 2 PEARL-I STUDY: INTERFERON-FREE REGIMENS OF ABT-450/R + ABT-267 WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 4 INFECTION

✍ Hezode, C.; Marcellin, P.; Pol, S.; Hassanein, T.; Fleischer-Stepniewska, K.; Ba 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

O1 SAPPHIRE II: PHASE 3 PLACEBO-CONTROLL

O1 SAPPHIRE II: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/R/ABT-267, ABT-333, AND RIBAVIRIN IN TREATMENT-EXPERIENCED ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1

✍ Zeuzem, S.; Jacobson, I.; Baykal, T.; Marinho, R.T.; Poordad, F.; Bourliere, M.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 152 KB

O60 SAPPHIRE I: PHASE 3 PLACEBO-CONTROLL

O60 SAPPHIRE I: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/R/ABT-267, ABT-333, AND RIBAVIRIN IN 631 TREATMENT-NAIVE ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1

✍ Feld, J.J.; Kowdley, K.V.; Coakley, E.; Sigal, S.; Nelson, D.; Crawford, D.; Wei 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

235 SAPPHIRE II: Phase 3 Placebo-Control

235 SAPPHIRE II: Phase 3 Placebo-Controlled Study of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333, and Ribavirin in 394 Treatment-Experienced Adults With Hepatitis C Virus Genotype 1

✍ Jacobson, Ira M.; Zeuzem, Stefan; Baykal, Tolga; Marinho, Rui T.; Poordad, Fred; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 361 KB

475 SAPPHIRE I: Phase 3 Placebo-Controll

475 SAPPHIRE I: Phase 3 Placebo-Controlled Study of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333, and Ribavirin in 631 Treatment-Naïve Adults With Hepatitis C Virus Genotype 1

✍ Kowdley, Kris V.; Feld, Jordan J.; Coakley, Eoin; Sigal, Samuel; Nelson, David R 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 825 KB